DRKS00006810招募中未知
Stool -therapy for inflammatory bowel disease
niversitätsklinik für Gastroenterologie, Hepatologie und Infektiologie0 个研究点目标入组 50 人开始时间: 2014年10月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •1. Patient information and consent
- •2. age> 18 years
- •3. Life expectancy> 6 months
- •4 Microbiological detection of CDI recurrence after at least an adequate standard antibiotic therapy with vancomycin> 125 mg / 4 times a day> 10 days or metronidazole 400 mg / 3 times a day
- •5. CDI-proof:
- •- Diarrhea (> 3 in two consecutive days)
- •- C. difficile toxin detection in stool
排除标准
- •1. Congenital or acquired immunodeficiency due to prolonged eg
- •Chemotherapy / drugs (eg, long-term therapy with prednisolone 60 mg)
- •2. stage HIV AIDS with CD4 cell counts below 250
- •3. pregnancy / lactation
- •4. Unstable circulatory condition (catecholamine / Respiratory
- •insufficiency)
研究者
相似试验
已完成
不适用
Medical rehabilitation in inflammatory bowel disease: effective and needed? A randomised controlled health care trial in a paradigmatic indicatioK50K51Crohn disease [regional enteritis]Ulcerative colitisDRKS00009912niversitätsklinikum Schleswig-Holstein, Campus Lübeck530
已完成
不适用
Integrated care for inflammatory bowel disease patients in the Netherlands with the novel telemedicine tool myIBDcoach: a randomized controled trialCrohn's disease10017969ulcerative colitisNL-OMON41419niversiteit Maastricht909
尚未招募
不适用
Optimizing the role of Thiopurines therapy in Inflammatory Bowel DiseaseCTRI/2020/05/024976Shailesh
进行中（未招募）
1 期
SB012 for the treatment of active ulcerative colitis: a clinical study in early development (phase IIa), conducted in several study centres, with random assignment of patients to active treatment or placebo, to investigate the efficacy, pharmacokinetics, tolerability, and safety of SB012 enema administered once dailyActive ulcerative colitisEUCTR2013-004599-36-DEsterna biologicals GmbH & Co. KG18
尚未招募
1 期
To understand a patients dietary habits and causes of underweight during Inflammatory Bowel DiseaseCTRI/2018/07/015091MsPavithra devadiga